Helios 发布:一滴血检测 1000+ 蛋白质生物标志物,打造健康基础模型
一个 CRISPR 诊断背景的团队做了家用一滴血检测,能测 1000 多种蛋白质标志物,再由 AI 智能体解读风险和给建议,拿到 YC 支持。做健康管理或蛋白质组学方向的团队可以看看它的产品思路。
Helios 由曾参与 CRISPR 诊断技术开发的 Omar Abudayyeh 团队推出,目标是构建一个模拟人体健康数十年变化的基础模型。产品核心是蛋白质组学检测:用户在家用无针、无痛设备自行采集一滴血液,即可测量 1000 种以上携带全身细胞与器官信号的蛋白质生物标志物。
检测结果由 Helios AI 智能体进行解读,向用户说明指标含义、提示健康风险并给出个性化建议。公司已获得 Y Combinator 和 Formation VC 支持,目前开放 myhelios.com 的候补名单。
个性化健康领域正在吸引更多融资团队入场,与传统年度体检相比,Helios 把采样频次和解读环节都放到家庭场景,用 AI 智能体替代临床医生的初步解读角色。对关注慢病预防与 longevity 赛道的开发者和投资者而言,这是蛋白质组学与基础模型结合的一个落地样本。
Personalized health is going to be huge! Helios reads 1,000+ protein biomarkers from a drop of blood collected at home. Their goal is a foundation model that simulates how your health changes over decades. Built by @omarabudayyeh and team, who helped pioneer CRISPR diagnostics. Omar Abudayyeh @omarabudayyeh Introducing Helios: measuring 1,000+ protein biomarkers from a drop of blood to help you live younger, longer. Here’s how it works: • Self-collect blood at home with a painless, needle-free device • We measure the proteins carrying signals from cells and organs throughout your body • Your Helios AI agent explains your results, highlights risks, and offers personalized guidance Proudly backed by Y Combinator and Formation VC. Join the waitlist at myhelios.com
This report is categorized under AITOP's "Products" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to AI developer toolchains, coding agents, and engineering workflows and US-China foundation model benchmarks and commercialization comparison. Key entities and technical topics under continuous tracking include Helios, agents, Y Combinator.
Source attribution: curated from elvis (@omarsar0).